SurModics SRDX 深 沪
等待开盘 11-03 09:30:00 美东时间
27.435
+0.265
+0.98%
华盛通- 最 高27.50
- 今 开27.15
- 成交量 12.50万股
- 最 低 27.10
- 昨 收 27.17
- 总市值 3.92亿
- 52周最高 40.385
- 市盈率 静 --
- 换手率 0.87%
- 52周最低 26.00
- 委 比 -74.93%
- 总股本 1429.76万
- 历史最高 82.35
- 量 比 1.81
- 振 幅 1.47%
- 历史最低 8.73
- 每 手 1
- 风险率 4.25%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Surmodics To Present PROWL Registry Sex-Specific Data From Analysis Of 160 Participants At TCT Symposium On Oct. 28
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that Dr. Peter Monteleone will present data from a sex-specific
10-28 04:11
GTCR purchase of Surmodics would hurt medical device market, FTC says
Private equity firm GTCR's planned purchase of medical device coatings firm Surmodics (NASDAQ:SRDX) would harm competition in the market, the Federal Trade Commission said on the first day of a trial ...
08-22 02:43
Barrington Research Reiterates Market Perform on Surmodicsto Market Perform
Barrington Research analyst Michael Petusky reiterates Surmodics (NASDAQ:SRDX) from Market Perform to Market Perform.
08-11 19:52
Surmodics Raises FY2025 Adj EPS Guidance from $(0.62)-$(0.42) to $(0.35)-$(0.20) vs $(0.55) Est; Raises FY2025 Sales Guidance from $114.000M-$117.000M to $116.500M-$118.500M vs $115.686M Est
Fiscal Year 2025 Financial GuidanceSurmodics is increasing its fiscal 2025 total revenue to a range of $116.5 million to $118.5 million, representing a decrease of 8% to 6% compared to fiscal 2024. Excluding SurVeil DCB
08-08 19:05
Earnings Scheduled For August 8, 2025
Companies Reporting Before The Bell • BeOne Medicines (NASDAQ:ONC) is expected ...
08-08 16:32
What's Next: Surmodics's Earnings Preview
Surmodics (NASDAQ:SRDX) is set to give its latest quarterly earnings report on ...
08-08 00:03
Surmodics falls as parties, FTC ask for extension of briefing schedule
Surmodics (NASDAQ:SRDX) fell 4.5% as private equity buyer GTCR as well as the Federal Trade Commission asked for an extension of a deadline for a preliminary injuction briefing. The FTC wants additio...
08-01 03:18
Scilex Holding Company Announces Deferral of Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from May 2, 2025 to a future date to be determined by the Board
Scilex Holding Company, headquartered in Palo Alto, California, announced that its Board of Directors has deferred the previously announced record date of May 2, 2025, for its preferred stock dividend to stockholders. The new record date will be determined at the Board's discretion, with the right to change or revoke the dividend. Scilex focuses on acquiring, developing, and commercializing non-opioid pain management products for acute and chroni...
06-23 20:50
9 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. ...
06-05 01:35
SurModics (SRDX) Gets a Hold from Barrington
Barrington analyst Michael Petusky maintained a Hold rating on SurModics (SRDX ...
03-31 19:45
